文献速递免疫规划传染病防控与疫情报告

墨西哥、巴西和马来西亚登革热流行区内脏趋向性与神经趋向性疾病背景发病率

Incidence rates of neurotropic-like and viscerotropic-like disease in three dengue-endemic countries: Mexico, Brazil, and Malaysia.
PubMed 文献 · Vaccine · 2019-02-28

巴西、墨西哥、马来西亚判定为确诊VLD的病例分别为5、57、56例,确诊NLD分别为103、29、26例;粗发病率VLD分别为1.17、2.60、1.48/10万人年,NLD分别为4.45、1.32、0.69/10万人年。这些背景发病率可为疫苗引入后病例评估提供参照。

要点

  • 巴西、墨西哥、马来西亚确诊VLD粗发病率分别为1.17、2.60、1.48/10万人年。
  • 三国确诊NLD粗发病率分别为4.45、1.32、0.69/10万人年。
  • 结果为四价登革热疫苗引入后VLD/NLD病例背景比较提供依据。

核心结论

  • 墨西哥、巴西和马来西亚获得的VLD与NLD背景发病率估计可为四价登革热疫苗引入后发生的病例提供背景参照。

研究设计与样本

  • 采用公开人口普查信息和行政数据估算 catchment 区域及发病率分母人群,并开展敏感性分析评估重要假设的影响。

主要发现

  • 巴西、墨西哥、马来西亚判定为确诊VLD的病例数分别为5例、57例、56例。
  • 巴西、墨西哥、马来西亚判定为确诊NLD的病例数分别为103例、29例、26例。
  • 巴西、墨西哥、马来西亚确诊VLD粗发病率分别为1.17、2.60、1.48/10万人年。
  • 巴西、墨西哥、马来西亚确诊NLD粗发病率分别为4.45、1.32、0.69/10万人年。

临床怎么用

  • 可为登革热疫苗引入后疑似VLD或NLD病例的背景发生率比较提供本地参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The background incidence of viscerotropic- (VLD) and neurotropic-like disease (NLD) unrelated to immunization in dengue-endemic countries is currently unknown. METHODS: This retrospective population-based analysis estimated crude and standardized incidences of VLD and NLD in twelve hospitals in Brazil (n = 3), Mexico (n = 3), and Malaysia (n = 6) over a 1-year period before the introduction of the tetravalent dengue vaccine. Catchment areas were estimated using publicly available population census information and administrative data. The denominator population for incidence rates was calculated, and sensitivity analyses assessed the impact of important assumptions. RESULTS: Total cases adjudicated as definite VLD were 5, 57, and 56 in Brazil, Mexico, and Malaysia, respectively. Total cases adjudicated as definite NLD were 103, 29, and 26 in Brazil, Mexico, and Malaysia, respectively. Crude incidence rates of cases adjudicated as definite VLD in Brazil, Mexico, and Malaysia were 1.17, 2.60, and 1.48 per 100,000 person-years, respectively. Crude incidence rates of cases adjudicated as definite NLD in Brazil, Mexico, and Malaysia were 4.45, 1.32, and 0.69 per 100,000 person-years, respectively. CONCLUSIONS: Background incidence estimates of VLD and NLD obtained in Mexico, Brazil, and Malaysia could provide context for cases occurring after the introduction of the tetravalent dengue vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cohen C, Moreira ED, Nañez H, et al. Incidence rates of neurotropic-like and viscerotropic-like disease in three dengue-endemic countries: Mexico, Brazil, and Malaysia. Vaccine. 2019. PMID: 30826144. doi:10.1016/j.vaccine.2019.01.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。